Xencor, Inc Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay
Xencor, Inc (XNCR) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay of 4.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent · last filed 2026-02-25
- Xencor, Inc defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2024 was 4.00%.
- Xencor, Inc defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2019 was 3.50%, a 0.00% change from fiscal 2018.
- Xencor, Inc defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2018 was 3.50%.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 12 month |
|---|---|---|
| 2024-12-31 | 4.00% 10-K · filed 2025-02-27 | |
| 2023-04-01 | 4.50% 10-K · filed 2026-02-25 | |
| 2020-03-31 | 4.00% 10-K/A · filed 2025-02-24 | |
| 2019-12-31 | 3.50% 10-K · filed 2020-02-25 | |
| 2018-12-31 | 3.50% 10-K · filed 2019-02-26 | |
| 2018-01-01 | 3.50% 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |